{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:40:50Z","timestamp":1715596850561},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s11154-011-9161-9","type":"journal-article","created":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T13:58:37Z","timestamp":1297173517000},"page":"11-14","source":"Crossref","is-referenced-by-count":8,"title":["Primary aldosteronism"],"prefix":"10.1007","volume":"12","author":[{"given":"Fumitoshi","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Iwakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikiyo","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Takase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,9]]},"reference":[{"key":"9161_CR1","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199812173392507","volume":"339","author":"A Ganguly","year":"1998","unstructured":"Ganguly A. Primary aldosteronism. N Engl J Med. 1998;339:1828\u201334.","journal-title":"N Engl J Med"},{"key":"9161_CR2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","volume":"66","author":"NM Kaplan","year":"1967","unstructured":"Kaplan NM. Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med. 1967;66:1079\u201390.","journal-title":"Ann Intern Med"},{"key":"9161_CR3","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1210\/jc.85.5.1863","volume":"85","author":"CE Fardella","year":"2000","unstructured":"Fardella CE, Mosso L, G\u00f3mez-S\u00e1nchez C, et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab. 2000;85:1863\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"9161_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.jhh.1001948","volume":"20","author":"JS Williams","year":"2006","unstructured":"Williams JS, Williams GH, Raji A, Jeunemaitre X, et al. Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens. 2006;20:129\u201336.","journal-title":"J Hum Hypertens"},{"issue":"Suppl 1","key":"9161_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0753-3322(00)80019-0","volume":"54","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Omura M. Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed Pharmacother. 2000;54 Suppl 1:83\u20135.","journal-title":"Biomed Pharmacother"},{"key":"9161_CR6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","volume":"217","author":"M Stowasser","year":"2004","unstructured":"Stowasser M, Gordon RD. Primary aldosteronism\u2014careful investigation is essential and rewarding. Mol Cell Endocrinol. 2004;217:33\u20139.","journal-title":"Mol Cell Endocrinol"},{"key":"9161_CR7","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1, 125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293\u2013300.","journal-title":"J Am Coll Cardiol"},{"key":"9161_CR8","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5 Pt 1","key":"9161_CR9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ajh\/3.5.360","volume":"3","author":"DH Streeten","year":"1990","unstructured":"Streeten DH, Anderson Jr GH, Wagner S. Effect of age on response of secondary hypertension to specific treatment. Am J Hypertens. 1990;3(5 Pt 1):360\u20135.","journal-title":"Am J Hypertens"},{"key":"9161_CR10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archsurg.1996.01430180072015","volume":"131","author":"O Celen","year":"1996","unstructured":"Celen O, O\u2019Brien MJ, Melby JC, Beazley RM. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg. 1996;131:646\u201350.","journal-title":"Arch Surg"},{"key":"9161_CR11","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","volume":"51","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Bolognesi M, Rizzoni D, et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension. 2008;51:1366\u201371.","journal-title":"Hypertension"},{"key":"9161_CR12","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"Mulatero P, Rabbia F, Milan A, et al. Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002;40:897\u2013902.","journal-title":"Hypertension"},{"key":"9161_CR13","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"9161_CR14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008;168:80\u20135.","journal-title":"Arch Intern Med"},{"key":"9161_CR15","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jc.2008-2116","volume":"94","author":"E Born-Frontsberg","year":"2009","unstructured":"Born-Frontsberg E, Reincke M, Rump LC, et al. Cardiovascular- and cerebrovascular comorbidites of hypokalemic- and normokalemic primary aldosteronism: results of the German Conn\u2019s Registry. 2009. J Clin Endocrinol Metab. 2009;94:1125\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"9161_CR16","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","volume":"90","author":"M Stowasser","year":"2005","unstructured":"Stowasser M, Sharman J, Leano R, et al. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab. 2005;90:5070\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"9161_CR17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Desideri G, et al. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension. 2006;48:232\u20138.","journal-title":"Hypertension"},{"key":"9161_CR18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/jc.2008-2245","volume":"94","author":"LA Sechi","year":"2009","unstructured":"Sechi LA, Di Fabio A, Bazzocchi M, Uzzau A, Catena C. Intrarenal hemodynamics in primary aldosteronism before and after treatment. J Clin Endocrinol Metab. 2009;94:1191\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"9161_CR19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","volume":"91","author":"F Fallo","year":"2006","unstructured":"Fallo F, Veglio F, Bertello C, et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab. 2006;91:454\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"9161_CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","volume":"25","author":"G Giacchetti","year":"2007","unstructured":"Giacchetti G, Ronconi V, Turchi F, et al. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens. 2007;25:177\u201386.","journal-title":"J Hypertens"},{"key":"9161_CR21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","volume":"53","author":"J Matrozova","year":"2009","unstructured":"Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2009;53:605\u201310.","journal-title":"Hypertension"},{"key":"9161_CR22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","volume":"50","author":"GP Rossi","year":"2007","unstructured":"Rossi GP, Belfiore A, Bernini G, et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension. 2007;50:424\u201331.","journal-title":"Hypertension"},{"key":"9161_CR23","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/HYPERTENSIONAHA.107.093468","volume":"50","author":"P Mulatero","year":"2007","unstructured":"Mulatero P, Bertello C, Garrone C, et al. Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension. 2007;50:e26\u20137.","journal-title":"Hypertension"},{"key":"9161_CR24","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004;136:1227\u201335.","journal-title":"Surgery"},{"key":"9161_CR25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/radiology.184.3.1509049","volume":"184","author":"JL Doppman","year":"1992","unstructured":"Doppman JL, Gill Jr JR, Miller DL, et al. Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology. 1992;184:677\u201382.","journal-title":"Radiology"},{"key":"9161_CR26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1291\/hypres.29.883","volume":"29","author":"M Omura","year":"2006","unstructured":"Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res. 2006;29:883\u20139.","journal-title":"Hypertens Res"},{"key":"9161_CR27","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1291\/hypres.30.1083","volume":"30","author":"F Satoh","year":"2007","unstructured":"Satoh F, Abe T, Tanemoto M, et al. Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res. 2007;30:1083\u201395.","journal-title":"Hypertens Res"},{"key":"9161_CR28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-151-5-200909010-00007","volume":"151","author":"MJ Kempers","year":"2009","unstructured":"Kempers MJ, Lenders JW, van Outheusden L, et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009;151:357\u20138.","journal-title":"Ann Intern Med"},{"key":"9161_CR29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14656566.9.4.509","volume":"9","author":"A Karagiannis","year":"2008","unstructured":"Karagiannis A, Tziomalos K, Papageorgiou A, et al. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opin Pharmacother. 2008;9:509\u201315.","journal-title":"Expert Opin Pharmacother"},{"key":"9161_CR30","first-page":"319","volume":"10","author":"PM Jansen","year":"2009","unstructured":"Jansen PM, van den Meiracker AH, Jan Danser AH. Aldosterone synthase inhibitors: pharmacological and clinical aspects. Curr Opin Investig Drugs. 2009;10:319\u201326.","journal-title":"Curr Opin Investig Drugs"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11154-011-9161-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T19:31:43Z","timestamp":1497900703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-011-9161-9"}},"subtitle":["A Japanese perspective"],"short-title":[],"issued":{"date-parts":[[2011,2,9]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9161"],"URL":"https:\/\/doi.org\/10.1007\/s11154-011-9161-9","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,9]]}}}